Silverarc Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-13,765
| Closed | -$4.79M | – | 81 |
|
|
2023
Q3 | $4.79M | Buy |
13,765
+590
| +4% | +$205K | 1.45% | 26 |
|
|
2023
Q2 | $4.64M | Sell |
13,175
-6
| -0% | -$2.11K | 1.43% | 22 |
|
|
2023
Q1 | $4.15M | Buy |
13,181
+1,797
| +16% | +$566K | 1.71% | 22 |
|
|
2022
Q4 | $3.29M | Buy |
11,384
+279
| +3% | +$80.6K | 0.94% | 34 |
|
|
2022
Q3 | $3.22M | Buy |
11,105
+691
| +7% | +$200K | 1.09% | 24 |
|
|
2022
Q2 | $2.94M | Buy |
10,414
+2,776
| +36% | +$782K | 0.9% | 23 |
|
|
2022
Q1 | $1.99K | Buy |
7,638
+2,638
| +53% | +$688 | 0.82% | 29 |
|
|
2021
Q4 | $1.1M | Buy |
+5,000
| New | +$1.1M | 0.45% | 58 |
|
|
2021
Q2 | – | Sell |
-7,500
| Closed | -$1.61M | – | 111 |
|
|
2021
Q1 | $1.61M | Buy |
7,500
+2,500
| +50% | +$537K | 0.88% | 41 |
|
|
2020
Q4 | $1.18M | Buy |
+5,000
| New | +$1.18M | 0.69% | 46 |
|